Calif) aortic stent graft were identified from a prospectively collected endovascular surgery registry. Of this group of patients, those who underwent an attempted placement of this device with a percutaneous technique were separately identified.
All patients had the standard accepted indications for abdominal aortic aneurysm repair and qualified as candidates for placement of the stent-graft device, according to a Food and Drug Administrationapproved investigational device protocol accepted by the institutional review board of the Cleveland Clinic Foundation. Initially, all patients were considered to be candidates for the percutaneous technique. After we gained some experience, patients with heavily calcified, small iliac arteries were excluded from the attempt at this technique.
Patients undergoing standard endovascular aneurysm repair had open surgical exposure of the common femoral artery below the inguinal ligament, through either a longitudinal or oblique incision, depending on surgeon preference. The introduction of the endovascular device was performed through common femoral arteriotomy over prepositioned, 0.035-in guidewires (Amplatz, Boston Scientific, Watertown, Mass). Patients were systemically heparinized with 5000 units of heparin, and the common femoral arteriotomy was repaired with either an interrupted or running suture closure after the completion of the endovascular repair.
Patients undergoing percutaneous endovascular aneurysm repair had retrograde percutaneous arterial access achieved with an 18-gauge needle, a 0.035-in guidewire, and an 8F sheath. Systemic heparinization was performed with 5000 units of heparin after femoral artery cannulation. The 8F sheath was then exchanged for a 10F Prostar device (Perclose), which was deployed with the sutures left unfastened (Figs 1 and 2 ). When the site accessed percutaneously was to be used for the insertion of the contralateral limb (16F outer diameter), the puncture site was then reaccessed by means of the reinsertion of the guidewire through the closure device lumen and the insertion of a 16F sheath over the guidewire.
In patients undergoing the insertion of the main body of the device (21F outer diameter) percutaneously, the wire was reinserted, and a second closure device was advanced over the wire. When the device was in position to be deployed, it was rotated 45 degrees and deployed in this orientation. Sutures from this second device were deployed between the sutures deployed from the previous device. These sutures were also left unfastened and were tagged separately from the other set of sutures. In five patients, a second guidewire was inserted, alongside the initial guidewire, through the 8F sheath. In these patients, the second Prostar device was then inserted alongside the first guidewire. The guidewire was then reinserted, and a 22F sheath was placed over the guidewire. This large caliber sheath does not have a typical hemostatic valve, but rather a "pinch valve," necessitating clamping of the flexible portion of the sheath when only the wire was in place. When manipulation of catheters or wires was performed, an 8F sheath was inserted within the larger sheath to obtain hemostasis at the hub. After the placement of the device and confirmation of the results with angiography, the previously placed sutures were vigorously irrigated to remove accumulated thrombus. The sutures were then fastened individually with a slipknot to allow individual closure of each suture onto the arterial entry site. When hemostasis was adequate after fastening of the sutures, a sterile dressing was placed over the entry site. In several instances, moderate oozing was noted from the access site. In those instances, the sutures were passed through a red rubber catheter, and tension was placed on the sutures. A hemostat was then used to maintain the tension on the sutures. A small fragment of Surgicel (Johnson and Johnson, Arlington, Tex) was placed beneath the catheter to tamponade the bleeding and achieve adequate hemostasis. Manual pressure was also held in these instances for 10 to 15 minutes. The Surgicel was left in place with the tamponading tourniquet for 1 to 2 hours, and the red rubber catheter was removed in the recovery room.
When the Prostar device was unsuccessful in closing the arterial entry site, surgical exposure of the artery was undertaken. If wire access to the artery had been maintained, the previously removed sheath was reinserted, and hemorrhage was controlled with placement of the sheath during the surgical exposure. When wire access to the vessel had been abandoned, manual pressure was held, when necessary, while proximal and distal control of the vessel was obtained. The arterial access site was then closed by means of a standard surgical technique, with either running or interrupted sutures. If necessary, femoral artery repair or external iliac endarterectomy was undertaken to improve the flow to the limb. We currently maintain wire access to the vessel until adequate hemostasis has been achieved.
As per the protocol for placement of this device, all patients had contrast and noncontrast computed tomography (CT) scans of the abdomen and pelvis performed 1 month after the placement of the endovascular graft. These scans included views of the femoral artery in the groins, allowing the evaluation of the artery for potential pseudoaneurysm formation. Additionally, patients underwent a preoperative and 1-month postoperative evaluation of lower-extremity arterial flow, with ankle brachial indices and pulse volume recordings. Clinical evaluation of incision sites was also performed 1 month postoperatively.
Records of patients undergoing percutaneous endovascular repair were retrospectively reviewed. All patients underwent a preoperative examination with spiral CT scanning, calibrated angiography, and intravascular ultrasound scanning. The results of these studies, with the operative notes of patients who underwent percutaneous placement, were reviewed to evaluate anatomic variables and operative events impacting the percutaneous technique and its success or failure. Operative times and the length of hospital stay were reviewed and compared between the two groups. Differences were compared with the use of the Student t test, and signifi- cance was ensured when the two-tailed P value was less than .05.
RESULTS
Seventeen patients underwent an attempted percutaneous placement of both the main body and contralateral limb (13 cases) or the contralateral limb alone (four cases) of an endograft device. Introduction of the main body was not attempted in four patients, because of the initial experience (one patient) or small iliac diameters or severe iliac tortuosity (three patients). In all cases, the device was able to be successfully deployed. The patients included 16 men and one woman, ranging in age from 62 to 93 years (mean age, 76.3 ± 7.8 years).
Successful percutaneous placement of the main body stent graft was achieved in eight of 13 cases (61.5%), whereas percutaneous contralateral limb placement was successful in 11 of 17 cases (64.7%; Table I ). In 13 patients in whom bilateral percutaneous deployment was attempted, six attempts (46.2%) were successful. Reasons for conversion to open groin incisions included inadequate hemostasis (six cases), iliofemoral dissection (four cases), device failure (one case), and compromised distal flow (one case).
Operative times in the two groups of patients and in the six patients in whom the main body and the contralateral limb were successfully deployed percutaneously are shown in Table II . Attempting percutaneous access did not significantly shorten the length of the procedure, although a trend toward a reduction of operative time existed (P = .06). The group with bilateral percutaneous success, however, had significantly (P < .001) shorter operative times.
Four of the six patients with bilateral percutaneous success went home on the first postoperative day. The other two patients were medically fit to go home the next day, but remained in the hospital for social reasons (one patient) and a psychiatric problem (one patient). A detailed look at reasons for device failure has proven helpful in revising our technique and informing others about the potential problems with this technique (Table III) . In the patients with inadequate hemostasis in particular, a number of specific problems were noted. In three patients with bleeding from the insertion of the main body of the device, a 24F sheath was used, because 22F sheaths were unavailable at the time. In patient number 4, an attempt was made to slip two separate knots down over the sheath at the same time. In doing this, the knots caught on each other and were unable to be advanced down to the arterial access site. In patient number 15, the needle and suture from a second device pierced a suture from the first device, thereby fixing it in place, and neither suture could be advanced as a slipknot. In patient number 17, the sutures did not have all the slack removed, the knots caught on a loose suture within the wound, and therefore, hemostasis could not be achieved. Because of each of these situations, we have altered our technique in performing this procedure.
Vessel dissection has also been noted in several of the patients. This problem has been noted primarily in patients with smaller iliac arteries, especially smaller external iliac arteries. This problem attains greater significance with the larger (22F) sheaths. Because of these findings, we have changed our technique and our examination of patients for suitability for this approach. Patients being considered for this approach will undergo a preoperative examination of the iliac vasculature with intravascular ultrasound scanning, and diameters larger than 7 mm throughout the iliac system are preferred.
Conversion to open groin incision was accompanied by external iliac endarterectomy and common femoral endarterectomy and prosthetic patch angioplasty in the two patients with vessel dissection and by a femoral crossover graft in the final patient with inflow problems. In patients in whom bleeding was the cause of conversion, primary vessel repair was able to be performed.
Nine of the 17 patients (53%) undergoing percutaneous repair required transfusion during their hospitalization. In contrast, 28% of patients with open surgical exposure of the femoral artery required a transfusion. Of the eight patients in whom percutaneous access for either the main device or contralateral limb failed, six patients (75%) required transfusion. Of the nine patients who had successful percutaneous placement of part or all of the device, three patients (25%) required transfusion.
No CT scan evidence of vessel abnormality was noted in any of the patients at 1 month postoperatively, and no evidence of pseudoaneurysm formation or wound complications was found by means of the clinical evaluation of the access sites and groin incisions.
DISCUSSION
Percutaneous repair of aortic aneurysms has been described in animal models 5 and in humans. 6 However, previous reports dealt with small-caliber devices; this is the first time on which devices with diameters greater than 16F have been reported. Additionally, in the only human study, an open surgical approach to the artery was still used before closure. 6 Limited access to the femoral artery has also been described before. 7 This approach, however, still required surgical exposure of the femoral sheath and parallels the closure noted in the study by Papazoglou et al. 6 In both of these studies, the arteries were accessed percutaneously; however, a limited dissection of the femoral sheath and a pursestring suture of the femoral sheath were performed to obtain closure of the access site. A recent clinical report has documented the technique of using a percutaneous suture closure device to seal large caliber arterial access sites. 8 In this report, the use of the device was limited to 16F access sites, with good technical results for adequate closure of the wound (100% success). The patients in the current series had a true attempt at complete percutaneous placement and closure without open surgical exposure. Despite large introducer sizes, percutaneous deployment of available aortoiliac endograft devices appeared technically feasible with a novel modification of the technique commonly used for percutaneous closure of smaller arterial defects.
Bleeding was the most common reason for the failure of the percutaneous technique. Several of the problems that led to bleeding have caused us to alter our method of percutaneous closure. Sutures catching on other sutures as they were advanced has led us to be much more careful in ensuring that all loops of the sutures are pulled taut and out of the wound before tying. Also, we now do not perform side-byside deployments of the device, in which two wires are used within the artery and Prostar devices are deployed, one over each wire. It has also become clear that sutures that are wet are slicker and allow easier slippage of the knot down to the access site. This is especially true for some of the lengthier procedures and when blood has dried on the sutures. Finally, three of the five bleeding failures occurred when a 24F sheath was used. We are not currently using sheaths with diameters this large to place the graft percutaneously. The design of sheaths is in flux. Improvements in sheath design can be expected to have a beneficial impact on blood loss. Vessel dissection with large sheaths and catheters is a risk, whether open or closed vessel access is attempted. Because the stent-graft deployment devices lack a tapered tip, the contralateral limb always requires the placement of a sheath. When advancing the main body of the device percutaneously, the outer diameter of the device introduced into the artery is increased by nearly 3F or 1 mm. This is especially significant in patients with small iliac vessels. We now use intravascular ultrasound to measure the external iliac arteries and do not attempt to place the larger (22F) sheath in vessels smaller than 7 mm in diameter.
Another risk of endovascular abdominal aortic aneurysm repair is distal embolization. One advantage to open femoral access is the ability to occlude the femoral artery distally and prevent embolization during the manipulation of wires and catheters. One of the 17 patients in this series experienced distal embolization. This patient had significant external iliac disease and a common iliac artery aneurysm on the side of embolization. Embolization was only noted after femorofemoral bypass grafting was performed. Despite the large diameter of the sheaths, which in part prevented embolization through occlusion of the iliac vessels, patients with a large amount of mural thrombus within their aneurysm may still be better suited to undergo open femoral access.
Patients in whom the percutaneous method failed were found to have small and/or tortuous iliac arteries, underlying occlusive disease, heavily calcified arteries, or difficulties related to the placement of the device or closure of the suture. Patients being considered for this approach should, therefore, be selected on the basis of an appropriate iliac artery caliber, without significant tortuosity, calcification, or occlusive disease. They should also have favorable anatomy to allow rapid exposure of the common femoral arteries (eg, absence of morbid obesity, lack of an earlier surgical exposure of the femoral artery), in case conversion to an open groin exposure is necessary.
The percutaneous approach will become more commonplace as the era of minimally invasive aortic aneurysm repair evolves. Newer generation devices are smaller and more flexible, with designs that will allow for easier traversal of tortuous arteries. Percutaneous techniques are possible today, with currently available technology. The future will undoubtedly bring even smaller, more trackable endograft introducer sheaths and more advanced percutaneous arterial closure devices, which will allow more patients to enjoy the benefits of a totally percutaneous approach to aortic aneurysm repair. 
